Beyond Fiber: New Research Unveils the Hidden Power of Plant-Based Diets on Gut Health on September 6, 2026 Posted by
Bridging the Gap: Can Community Optometrists Revolutionize Wet AMD Management? on September 6, 2026 Posted by
The Silent Pandemic: Why Loneliness is the Next Great Public Health Frontier on September 6, 2026 Posted by
Tactical Preview: Singapore vs. Thailand – A Battle for Southeast Asian Supremacy on September 6, 2026 Posted by
A Medical Milestone: Experimental Oral Drug ‘Enlicitide’ Promises to Revolutionize Cholesterol Management on September 6, 2026 Posted by
Oregon Diagnostic Testing Operator Pleads Guilty in Multimillion-Dollar Healthcare Fraud Scheme on September 6, 2026 Posted by
Beyond Fiber: New Research Unveils the Hidden Power of Plant-Based Diets on Gut Health on September 6, 2026 Posted by
Bridging the Gap: Can Community Optometrists Revolutionize Wet AMD Management? on September 6, 2026 Posted by
The Silent Pandemic: Why Loneliness is the Next Great Public Health Frontier on September 6, 2026 Posted by
Posted in Medical Innovations A Major Setback in Cardiology: Novartis’ Pelacarsen Fails Pivotal Phase 3 Trial on September 4, 2026
Posted in Medical Innovations Novartis’ Remibrutinib: A Potential Paradigm Shift in the High-Stakes Race for BTK Inhibition on September 1, 2026
Posted in Medical Innovations Setback in the "Immune Reset" Frontier: Novartis and Bristol Myers Pause CAR-T Autoimmune Trials on August 31, 2026
Posted in Medical Innovations Novartis’ Pacibekitug Shows Promise in Midstage Cardiovascular Trial: A New Frontier in Inflammation Management on August 29, 2026
Posted in Medical Innovations Novartis Navigates the "Patent Cliff" Era: Strategic Pipeline Shifts and Financial Resilience on July 22, 2026
Posted in Medical Innovations Novartis Enters the ADC Arena: A $1.5 Billion Strategic Pivot into Next-Generation Oncology on July 7, 2026
Posted in Medical Innovations Novartis Partners with Antares Therapeutics: A Strategic Pivot in Oncology R&D on June 26, 2026
Posted in Medical Innovations Novartis’ $12 Billion Bet on RNA Medicine Yields Promising Results for Rare Muscle Disease on June 14, 2026
